Decitabine-containing G-CSF priming regimen overcomes resistance of primary mediastinal neoplasm from early T-cell precursors to conventional chemotherapy: a case report

Decitabine-containing G-CSF priming regimen overcomes resistance of primary mediastinal neoplasm from early T-cell precursors to conventional chemotherapy: a case report

Yuhuan Yang,1,* Shuna Yao,1,* Jiuyang Zhang,1 Zheng Yan,1 Junfeng Chu,1 Haiying Wang,1 Zhihua Yao,1 Fan Zhang,2 Qingxin Xia,3 Yanyan Liu11Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, People’s Republic of China; 2Department of Centra...

Full description

Bibliographic Details
Main Authors: Yang Y, Yao S, Zhang J, Yan Z, Chu J, Wang H, Yao Z, Zhang F, Xia Q, Liu Y
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:OncoTargets and Therapy
Subjects:
Early T-cell precursor
Decitabine
G-CSF Priming
T-lymphoblastic lymphoma
Online Access:https://www.dovepress.com/decitabine-containing-g-csf-priming-regimen-overcomes-resistance-of-pr-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/decitabine-containing-g-csf-priming-regimen-overcomes-resistance-of-pr-peer-reviewed-article-OTT

Similar Items